P300 delay and attenuation in schizophrenia: Reversal by neuroleptic medication

Biological Psychiatry

Volumn 44, Issue 6, 1998, Pages 466-474

  Coburn, Kerry L ^a,b   Shillcutt, Samuel D ^a,c   Tucker, Karen A ^b   Estes, Kristi M ^b   Brin, Foster B ^c   Merai, Prakash ^c   Moore, Norman C ^a,b  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL CENTER OF CENTRAL GEORGIA   (United States)

^c Central State Hospital   (United States)

Author keywords

Electroencephalography; Haloperidol; Neuroleptic; P300; Remoxipride; Schizophrenia

Indexed keywords

AMOBARBITAL; BENZATROPINE; CLONIDINE; DIPHENHYDRAMINE; HALOPERIDOL; LORAZEPAM; LOXAPINE; NEUROLEPTIC AGENT; OXYBUTYNIN; PROCHLORPERAZINE; REMOXIPRIDE; THIORIDAZINE;

ADULT; AMPLITUDE MODULATION; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LATENT PERIOD; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; WAVEFORM;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032530219     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00402-2     Document Type: Article

References (38)

1. Barrett K., McCallum W.C., Pocock P.V. Brain indicators of altered attention and information processing in schizophrenic patients. Br J Psychiatry. 148:1986;414-420.
2. Blackwood D.H.R., Whalley L.J., Christie J.E., Blackburn I.M., St Clair D.M., McInnes A. Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry. 150:1987;154-160.
3. Brecher M., Begleiter H. Event-related brain potentials to high-incentive stimuli in unmedicated schizophrenic patients. Biol Psychiatry. 18:1983;661-673.
4. Courchesne E., Elmasian R., Yeung-Courchesne R. Electrophysiological correlates of cognitive processes. The P3b and Nc components. Basic clinical and developmental research. Halliday A.M., Butler S.R., Paul R. A Textbook of Clinical Neurophysiology. 1986;138-156 Wiley, New York.
5. Duncan C.C., Perlstein W.M., Morihisa J.M. The P300 metric in schizophrenia Effects of probability and modality . Johnson R., Rohrbaugh J.W., Parasuraman R. Current Trends in Event-Related Potential Research (EEG suppl 40). 1987;670-674 Elsevier, Amsterdam.
6. Duncan-Johnson C.C., Donchin E. The P300 component of the event-related brain potential as an index of information processing. Biol Psychol. 14:1982;1-52.
7. Eikmeier G., Lodemann E., Zerbin D., Gastpar M. P300, clinical symptoms, and neuropsychological parameters in acute and remitted schizophrenia A preliminary report . Biol Psychiatry. 31:1992;1065-1069.
8. Faux S.F., Shenton M.E., McCarley R.W., Torello M.W., Duffy F.H. Differentiation of schizophrenics and normal controls is enhanced by the Goodin subtraction procedure. Int J Neurosci. 39:1988;117-135.
9. Faux S.F., Torello M.W., McCarley R.W., Shenton M.E., Duffy F.H. P300 in schizophrenia Confirmation and statistical validation of temporal region deficit in P300 topography . Biol Psychiatry. 23:1988;776-790.
10. Faux S.F., McCarley R.W., Nestor P.G., Shenton M.E., Pollak S.D., Penhune V., et al. P300 topographic asymmetries are present in unmedicated schizophrenics. Electroencephalogr Clin Neurophysiol. 88:1993;32-41.
11. Ford J.M., Pfefferbaum A., Roth W. P3 and schizophrenia. Ann NY Acad Sci. XX:1992;146-162.
12. Hillyard S.A., Picton T.W. Electrophysiology of cognition. Mountcastle V.B., Plum F., Geiger S.R. Handbook of Physiology. (Section 1: The nervous system, Chapt. 13). 1987;519-584 American Physiological Society, Bethesda, MD.
13. Jin Y., Potkin S.G., Sandman C. Clozapine increases EEG photic driving in clinical responders. Schizophr Bull. 21:1995;263-268.
14. Kidogami Y., Yoneda H., Asaba H., Sakai T. P300 in first degree relatives of schizophrenics. Schizophr Res. 6:1992;9-13.
15. Knight R.T. Decreased response to novel stimuli after prefrontal lesions in man. Electroencephalogr Clin Neurophysiol. 54:1984;9-20.
16. Knight R.T., Scabini D., Woods D.L., Clayworth C. Differential effects of parietal or temporal-parietal lesions on N200 and P300. Soc Neurosci Abstr. 22:1987;521.
17. Kutcher S.A., Blackwood D.H.R., St Clair D.M., Gaskell D.G., Muir W.J. P3 abnormality in borderline personality disorder and schizophrenia. Arch Gen Psychiatry. 44:1987;645-650.
18. Lehman D. Past, present and future of topographic mapping. Brain Topogr. 3:1990;191-202.
19. McCarley R.W., Faux S.F., Shenton M., LeMay M., Cane M., Ballinger R., et al. CT abnormalities in schizophrenia; A preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms. Arch Gen Psychiatry. 46:1989;698-708.
20. McCarley RW, Holinger DP (1990): Data presented at the Annual Meeting of the Society for Psychophysiological Research; October 18, 1990; Boston, MA.
21. McCarley R.W., Faux S.F., Shenton M.E., Nestor P.G., Holinger D.P. Is there P300 asymmetry in schizophrenia? Arch Gen Psychiatry. 48:1991;380-381. (Letter to the editor).
22. Maurer K., Dierks T., Ihl R., Laux G. Mapping of evoked potentials in normals and patients with psychiatric diseases. Mauer K. Topographic Brain Mapping of EEG and Evoked Potentials. 1989;458-473 Springer-Verlag, Berlin.
23. Meador K.J., Loring D.W., Adams R.J., Paten B.R., Davis H.C. Central cholinergic systems and the P3 evoked potential. Int J Neurosci. 33:1987;199-205.
24. Meador K.J., Loring D.W., Lee G.P., Taylor H.S., Hughes D.R., Feldman D.S. In vivo probe of central cholinergic systems. J Gerontol Med Sci. 43:1988;M158-M162.
25. Meador K.J., Loring D.W., Davis H.C., Sethi K.D., Patel B.R., Adams R.J. Cholinergic and serotonergic effects on the P3 potential and recent memory. J Clin Exp Neuropsychol. 11:1989;252-260.
26. Moore N.C., Davis K., Hall M.C.S., Tucker K.A., Coburn K.L. Latency and amplitude of the P300 Button press compared with mental counting of target stimuli . Brain Topogr. 5:1993;307-308.
27. Morstyn R., Duffy F.H., McCarley R.W. Altered P300 topography in schizophrenia. Arch Gen Psychiatry. 40:1983;729-734.
28. Ogura C., Nageishi Y., Matsubayashi M., Omura F., Kishimoto A., Shimokochi M. Abnormalities in event-related potentials, N100, P200, P300 and slow wave in schizophrenia. Jpn J Psychiatry Neurol. 45:1991;57-65.
29. Oldfield R.C. The assessment and analysis of handedness The Edinburgh Inventory . Neuropsychologia. 9:1971;97-113.
30. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol Rep. 10:1962;799-812.
31. Pfefferbaum A., Wenegrat B.G., Ford J.M., Roth W.T., Kopell B.S. Clinical application of the P3 component of event-related potentials II. Dementia, depression and schizophrenia . Electroencephalogr Clin Neurophysiol. 59:1984;104-124.
32. Pfefferbaum A., Ford J.M., White P.M., Roth W.T. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms. Arch Gen Psychiatry. 46:1989;1035-1044.
33. Pfefferbaum A., Ford J.M., White P.M., Roth W.T., Mathalon D.H. Letter to the editor. Arch Gen Psychiatry. 48:1991;381-383.
34. Pritchard W.S. Cognitive event-related potential correlates of schizophrenia. Psychol Bull. 100:1986;43-66.
35. Romani A., Merrello L., Gozzoli L., Zerbi G.F., Grassi M., Cosi V. P300 and CT scans in patients with chronic schizophrenia. Br J Psychiatry. 151:1987;506-513.
36. Roth W.T., Horvath T.B., Pfefferbaum A., Tinklenberg J.R., Mezzich J.E., Kopell B.S. Late event-related potentials in schizophrenia. Begleiter H. Evoked Brain Potentials and Behavior (Downstate Series of Research in Psychiatry and Psychology, vol 2). 1979;499-515 Plenum, New York.
37. Roth W.T., Pfefferbaum A., Kelley A.F., Berger P.A., Kopell B.S. Auditory event-related potentials in schizophrenia and depression. Psychiatry Res. 4:1981;199-212.
38. St Clair D., Blackwood D., Muir W. P300 abnormality in schizophrenic subtypes. J Psychiatry Res. 23:1989;49-55.